Chapters

Transcript

Video

How does NGS vs. "Hot Spot" testing address the changes in cancer treatment, toward the use of molecularly targeted drugs prescribed to selected subsets of patients across multiple tumor types?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Samuel Klempner, MD

Samuel Klempner, MD

Director of Precision Medicine
The Angeles Clinic and Research Institute
Cedars-Sinai Medical Center
Los Angeles, CA